Defense Department Deal Ignites Bidding War

Allscripts (MDRX), Computer Sciences (CSC), and Hewlett Packard (HPQ) are teaming up in a bid to win an $11 billion contract with the Department of Defense to create a new electronic health records system.

Jun 29, 2014 at 2:30PM

It didn't take Allscripts (NASDAQ:MDRX) long to forge its own alliance to compete against electronic health records giant Epic and IBM (NYSE:IBM) for a Defense Department modernization contract that could prove worth $11 billion.

Last month, Epic, the largest provider of electronic health records software, and computer and security Goliath IBM announced they were teaming up to compete for a contract to replace the Government's current disjointed records sharing system.

Allscripts responded this week by reporting that it is linking up with Computer Sciences (NYSE:CSC) and Hewlett-Packard (NYSE:HPQ) to make its own proposal for the DoD payday.


Source: Secretary of Defense Flickr

Tapping a big unmet need
In the wake of reports suggesting poor service at the Veteran's Affairs office, it's probably not shocking to learn that the DoD is eager to start from scratch with an all new medical records system that can better communicate across its network of 412 medical clinics and 65 military hospitals.

The project is likely to be massive given that the military provides medical care to more than 10 million servicemen and women.

As a result, the proposed $11 billion value of the contract stands to be a game-changer for the companies making the winning bid. To put the sheer size of it in context, Accenture estimates that the total EHR market will be worth just $10 billion next year.

Or looking at the contract's size another way, consider that Allscripts, which controls between 9% and 10% market share in the EHR market, posted sales of just $1.2 billion in 2013.


Department of Defense Flickr

Getting their ducks in a row
Epic and IBM were the first to announce that they would compete for the business and those two companies certainly bring a lot to the bargaining table.

Epic's customers include 250 of the largest hospitals in the United States, and in addition to being the nation's largest EHR company, it's also a top five player overseas too.

IBM also has solid ties to Washington through its federal health care business, which will spearhead the proposal. IBM already provides hardware, software, and security to a slate of Federal agencies.

In order to trump Epic and IBM's advantages, Allscripts is also linking up with a team that carries significant sway among the military's top brass.

Virginia based Computer Sciences, the company that will be coordinating the team's effort and whose Chief Medical Officer is a Navy physician, has a long history of inking deals with the DoD. The company gets a third of its revenue from government contracts and $2.4 billion of the $4.1 billion in sales notched by its North American Public Sector, or NPS, business unit came from the DoD in the past 12 months.

Hewlett-Packard, which will provide the hardware behind the trio's bid, is also experienced in winning government contracts. Hewlett already works with the Department of Health and Human Services and Veteran's Affairs, and its products and services are used to handle more than 2.8 billion health care transactions a year.


Source: Secretary of Defense Flickr

For its part, Allscripts will provide the EHR software and while it's not as big a player as Epic, it still boasts an impressive customer base that stretches across more than 1,500 hospitals and 180,000 doctors.

Fool-worthy final thoughts
While Epic is the largest EHR provider, it markets a closed system that doesn't play well with systems developed by other companies like Allscripts. That means Allscripts will likely be touting its open architecture design that allows it to share information across platforms built by Epic, Cerner, and others.

Whether that advantage is enough to give it an edge in winning the contract remains to be seen, but Allscripts could definitely use a win.

The company has been struggling to maintain its market share as Epic's foothold strengthens and new competition enters the market from small players like athenahealth.

Last quarter, those pressures were responsible for Allscripts sales dipping to $345 million last quarter, down a little year-over-year from $348 million. Although the contract would be a windfall for the company, I'm content to remain a spectator on this one, at least until it becomes clearer which bidder has the advantage.

An even bigger investment opportunity?
Allscripts has a huge opportunity with this contract, but it's already been well publicized. The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool recommends Athenahealth. The Motley Fool owns shares of International Business Machines. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information